1,721,068 research outputs found
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Variations on the Author
Full text link“Variations on the Author” discusses two of Eduardo Coutinho’s recent films (Um Dia na Vida, from 2010, and Últimas Conversas, posthumously released in 2015) and their contribution to the general question of documentary authorship. The director’s filmography is characterized by a consistent yet self-effacing form of authorial self-inscription: Coutinho often features as an interviewer that rather than express opinions propels discourses; an interviewer that is good at listening. This mode of self-inscription characterizes him as an author who is not expressive but who is nonetheless markedly present on the screen. In Um Dia na Vida, however, Coutinho is completely absent form the image, while Últimas Conversas, on the contrary, includes a confessional prologue that moves the director from the margins to the center of his films. This article examines the ways in which these works stand out in the filmography of a director who offers new insights into the notion of cinematic authorship
Relationship between motor mortex excitability and locomotor disorders in Parkinsonian patients
No full textLes travaux réalisés lors de cette thèse ont porté sur le cortex moteur et les troubles de la marche de patients atteints de la maladie de Parkinson (MP). L’atteinte fonctionnelle des aires motrices corticales dans la MP et leur implication dans la physiopathologie des désordres moteurs a surtout été établie à partir de données issues des aires corticales des membres supérieurs. L’analyse électrophysiologique par stimulation magnétique transcranienne réalisée dans ces travaux de thèse a exploré les aires motrices corticales des membres inférieurs et révélé des troubles d’excitabilité différents de ceux classiquement décrits dans les aires corticales des membres supérieurs. En effet, il ressort principalement de l’étude sur le membre inférieur une diminution de la facilitation intracorticale (FIC) alors que la littérature décrit essentiellement pour les aires motrices corticales des membres supérieurs une altération des mécanismes inhibiteurs intracorticaux. Les anomalies corticales mises en évidence sont corrélées avec les paramètres locomoteurs affectés par la maladie, longueur d’enjambée et vitesse de marche. L’analyse des patients avec et sans traitement a permis de montrer que la supplémentation dopaminergique agit à la fois au niveau cortical et locomoteur normalisant partiellement les déficits observés. Les anomalies de FIC des aires corticales motrices des membres inférieurs paraissent donc être impliquées dans la physiopathologie des troubles de la marche dans la MP et pourraient de ce fait constituer un paramètre d’évaluation et un objectif thérapeutique de choix. L’utilisation de la stimulation magnétique transcranienne répétitive couplée à la neuronavigation permettrait d’explorer cette dernière piste.This thesis aims to study the relationships between motor cortex impairment and locomotor disorders in Parkinsonian patients (PP). Most of the previous studies have focused on the upper limb cortical areas showing the existence of an imbalance in cortical excitability, which mainly evolves towards a state of impaired intracortical inhibition. However, just a few studies have been devoted so far to the exact cortical abnormalities responsible for Parkinsonians’ gait disorders. The transcranial magnetic stimulation (TMS) studies presented here demonstrate that the excitability abnormalities occurring in PP differ between the cortical areas associated with the lower and upper limbs, since defective intracortical facilitation (ICF) processes were mainly detected in the lower limbs cortical areas. Furthermore, these specific excitability abnormalities identified seem to be involve in the genesis of the hypokinetic locomotor component since correlations were established between the ICF level and the shortened stride length (and by correlates, with the reduced velocity). Patients were assessed with and without dopaminergic substitution treatment (DST). We found that DST modified significantly both the cortical excitability abnormalities and the defective locomotor parameters. Impaired facilitatory processes in lower limbs cortical areas may be involved in the pathophysiology of gait disorders in PD. This hypothesis should be addressed in an experiment coupling repetitive TMS and neuronavigation
Appropriate Similarity Measures for Author Cocitation Analysis
Full text linkWe provide a number of new insights into the methodological discussion about author cocitation analysis. We first argue that the use of the Pearson correlation for measuring the similarity between authors’ cocitation profiles is not very satisfactory. We then discuss what kind of similarity measures may be used as an alternative to the Pearson correlation. We consider three similarity measures in particular. One is the well-known cosine. The other two similarity measures have not been used before in the bibliometric literature. Finally, we show by means of an example that our findings have a high practical relevance.information science;Pearson correlation;cosine;similarity measure;author cocitation analysis
Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3)
Full text linkBackgroundThe treatment of levodopa-induced dyskinesia in Parkinson's disease (PD) is an unmet need with no approved drug therapy.ObjectiveThe purpose of this study was to investigate the efficacy and safety of 274 mg ADS-5102 (amantadine) extended-release capsules (equivalent to 340-mg amantadine HCl) for levodopa-induced dyskinesia in a randomized controlled trial.MethodsPD patients with ≥1 hour of troublesome dyskinesia and at least mild functional impact were randomized to placebo or ADS-5102 once daily at bedtime for 13 weeks. The primary efficacy analysis was based on change from baseline to week 12 on the Unified Dyskinesia Rating Scale total score in the modified intent-to-treat population. OFF time was a key secondary measure.ResultsAt week 12, least-squares mean change in the Unified Dyskinesia Rating Scale was -20.7 (standard error 2.2) for ADS-5102 (n = 37) and -6.3 (standard error 2.1) for placebo (n = 38; treatment difference -14.4, 95% confidence interval -20.4 to -8.3, P < .0001), indicating improvement in levodopa-induced dyskinesia. OFF time decreased 0.5 hours (standard error 0.3) for ADS-5102 from a baseline mean of 2.6 hours and increased 0.6 hours (standard error 0.3) for placebo from a baseline mean of 2.0 hours (treatment difference -1.1 hours, 95% confidence interval -2.0 to -0.2, P = .0199). The most common adverse events (ADS-5102 versus placebo) included dry mouth (13.5% versus 2.6%), nausea (13.5% versus 2.6%), decreased appetite (10.8% versus 0%), insomnia (10.8% versus 0%), orthostatic hypotension (10.8% versus 0%), constipation (8.1% versus 0%), falls (8.1% versus 5.3%), and visual hallucinations (8.1% versus 5.3%). Adverse events led to treatment discontinuation in 19% versus 8%, respectively.ConclusionADS-5102 274 mg is an oral pharmacotherapy demonstrating a significant decrease in levodopa-induced dyskinesia and improving OFF time. © 2017 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society
Dispelling the Myths Behind First-author Citation Counts
Full text linkWe conducted a full-scale evaluative citation analysis study of scholars in the XML research field to explore just how different from each other author rankings resulting from different citation counting methods actually are, and to demonstrate the capability of emerging data and tools on the Web in supporting more realistic citation counting methods. Our results contest some common arguments for the continued
use of first-author citation counts in the evaluation of scholars, such as high correlations between author rankings by first-author citation counts and other citation
counting methods, and high costs of using more realistic citation counting methods that are not well-supported by the ISI databases. It is argued that increasingly available digital full text research papers make it possible for citation analysis studies to go beyond what the ISI databases have directly supported and to employ more
sophisticated methods
koamabayili/VECTRON-author-checklist: VECTRON author checklist
No full textWe have done our best to complete the author checklist relating to the use of animals in the hut study. Note that the objective for the hut study was to evaluate the IRS treatment applications for residual efficacy against Anopheles mosquitoes, including the local An. coluzzii mosquito population. Cows were only used to attract mosquitoes into the huts and no tests were carried out directly on the cows. The author checklist is intended for use with studies where experiments are carried out on animals, which is why we have had such difficulty in completing this for the hut study, as many of the questions do not relate to how the cows were used
- …
